Israeli bio-tech firm ElMindA have developed the world's first FDA approved brain assessment tool, which can visualise trauma and illnesses by creating a three dimensional image of neural pathways. The new tool is designed to help doctors diagnose patients with neurological disorders such as epilepsy or Parkinson's disease.
Israeli bio-tech firm ElMindA have developed the world's first FDA approved brain assessment tool, which can visualise trauma and illnesses by creating a three dimensional image of neural pathways. The World Economic Forum named ElMindA one of the 49 most innovative startups in the world today.